Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Pavla Bradáčová"'
Autor:
Pavla Bradáčová, Luděk Slavík, Jana Úlehlová, Eva Kriegová, Eliška Jará, Lenka Bultasová, David Friedecký, Jana Ullrychová, Jana Procházková, Antonín Hluší, Gayane Manukyan, Lenka Štefaničková
Publikováno v:
Biomedicines, Vol 11, Iss 12, p 3329 (2023)
The aim of this study was to determine the thrombogenicity of lupus anticoagulant (LA) antibodies using a modified thrombin generation assay (TGA) with the addition of activated protein C (APC) in a group of 85 patients with LA-positive samples. Of t
Externí odkaz:
https://doaj.org/article/7a12b69ca1734d7fb9c972e4c493006b
Autor:
Pavla Bradáčová, Luděk Slavík, Adéla Skoumalová, Jana Úlehlová, Eva Kriegová, Gayane Manukyan, David Friedecký, Barbora Piskláková, Jana Ullrychová, Jana Procházková, Antonín Hluší
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 16, p 8973 (2022)
Antiphospholipid syndrome (APS) is a hypercoagulable state accompanied by the presence of heterogeneous antiphospholipid antibodies (aPL), which nonspecifically affect hemostasis by the presence of lupus anticoagulans (LA), anticardiolipin antibodies
Externí odkaz:
https://doaj.org/article/a7c6b3a5a3114a1098d67c520bd61e57
Autor:
Jana Úlehlová, Barbora Piskláková, Eliška Ivanovová, Jana Procházková, Pavla Bradáčová, Aleš Kvasnička, David Friedecký, Luděk Slavík
Publikováno v:
Diagnostics, Vol 11, Iss 11, p 2027 (2021)
Background: The effect of direct oral anticoagulants (DOAC) on laboratory tests dependent on the production of their targets, factor IIa and factor Xa, is a well-known problem and can cause both false positive and negative results. In particular, the
Externí odkaz:
https://doaj.org/article/1ed979c261064a0fbcd435102c9d5af1
Autor:
Procházková J, Luděk Slavík, Aleš Kvasnička, David Friedecký, Eliška Ivanovová, Barbora Piskláková, Jana Ulehlova, Pavla Bradáčová
Publikováno v:
Diagnostics, Vol 11, Iss 2027, p 2027 (2021)
Diagnostics
Volume 11
Issue 11
Diagnostics
Volume 11
Issue 11
Background: The effect of direct oral anticoagulants (DOAC) on laboratory tests dependent on the production of their targets, factor IIa and factor Xa, is a well-known problem and can cause both false positive and negative results. In particular, the
Autor:
Jana Ulehlova, Eva Kriegova, Ludek Slavik, Jana Ullrychova, Adela Skoumalova, Pavla Bradáčová, Procházková J, Antonin Hlusi, Gayane Manukyan
Publikováno v:
Biomedicines
Biomedicines, Vol 9, Iss 166, p 166 (2021)
Biomedicines, Vol 9, Iss 166, p 166 (2021)
Antiphospholipid syndrome (APS) is a hypercoagulation condition associated with the incidence of heterogenic antiphospholipid antibodies (aPLs), which non-specifically affect hemostasis processes. APS is clinically manifested by recurrent arterial an
Autor:
Antonin Hlusi, Kateřina Chasáková, M Palova, Luděk Slavík, Jana Ulehlova, Alice Entrová, Pavla Bradáčová
Publikováno v:
Journal of medical systems. 44(9)
Pneumatic tube transport systems (PTS) for delivery of patient samples to a hemostasis laboratory are often used to reduce turnaround time for vital analyses. PTS in our hospital has the ability to regulate the transport speed in the range of 3–6 m
Autor:
Pavla Bradacova, Ludek Slavik, Jana Ulehlova, Adela Skoumalova, Jana Ullrychova, Jana Prochazkova, Antonin Hlusi, Gayane Manukyan, Eva Kriegova
Publikováno v:
Biomedicines, Vol 9, Iss 2, p 166 (2021)
Antiphospholipid syndrome (APS) is a hypercoagulation condition associated with the incidence of heterogenic antiphospholipid antibodies (aPLs), which non-specifically affect hemostasis processes. APS is clinically manifested by recurrent arterial an
Externí odkaz:
https://doaj.org/article/239cf1fef2f545fa9276e15dc2c47141